How price evidence is selected, checked and corrected.
The publication standard separates source facts, automated validation, editorial decisions and external professional advice so readers can see what has—and has not—been reviewed.
Last updated 4 August 2026
Source standard
- Prices come from provider-owned pages or provider-supplied first-party evidence, not another comparison database.
- An exact dose-price match, provider URL, observation time and source-check time are retained.
- Prices that exceed the public freshness limit are suppressed rather than presented as current.
- Starting, standard and programme prices remain labelled; discounts and referral codes are not folded into the public amount.
Authorship and review
Public comparison pages are authored by the PharmacyScore editorial team. Automated checks validate required fields, source provenance, freshness, canonical URLs, metadata, structured data and internal links before release.
An editorial review confirms that the visible claims follow the captured evidence and that neutral A-Z ordering is preserved. This process is data and publication review, not clinical advice.
Medicines-advertising and legal status
Mounjaro is a prescription-only medicine. Public pages are deliberately factual, non-affiliate and non-promotional, but PharmacyScore does not describe internal checks as CAP Copy Advice or independent legal approval.
The current external UK medicines-advertising review remains a separate launch gate. Until written advice exists for the exact presentation, readers should not infer that CAP, the MHRA, the GPhC, the NHS or a law firm has approved the site.
Corrections and conflicts
Pharmacies can correct facts without paying. Commercial customers cannot buy rank, edit independent evidence or prevent a supported correction. Material changes retain an evidence trail.
See the full methodology, corrections process and source and rights notice.